欧洲超声波凝胶市场，按类型（无菌和非无菌）、应用（腹部超声、产科超声、宫腔超声、盆腔超声、肌肉骨骼超声、乳腺超声、前列腺超声、颈动脉超声、静脉超声（四肢）、阴囊超声、甲状腺超声等）、最终用户（医院、诊所、诊断中心、门诊手术中心等）、分销渠道（零售、在线销售和直接招标）划分 - 行业趋势和预测到 2029 年。
欧洲超声波凝胶市场分析与洞察
超声波凝胶是广泛使用的凝胶之一，用于各种超声波检查，包括宫腔超声检查、产科超声检查、腹部超声检查、乳房超声检查、颈动脉超声检查、肌肉骨骼超声检查、盆腔超声检查、前列腺超声检查、阴囊超声检查、甲状腺超声检查、静脉超声检查等。超声波凝胶是一种抗 TNF 药物，用于治疗炎症症状。医疗专业人员使用生物超声波凝胶进行清晰而准确的诊断。
预计欧洲超声波凝胶市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场的复合年增长率为 6.1%，预计到 2029 年将达到 39,078.25 万美元。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制 2019-2014） |
|
定量单位 |
收入（千美元） |
|
涵盖的领域 |
按类型（无菌和非无菌）、应用（腹部超声、产科超声、宫腔超声、盆腔超声、肌肉骨骼超声、乳腺超声、前列腺超声、颈动脉超声、静脉超声（四肢）、阴囊超声、甲状腺超声等）、最终用户（医院、诊所、诊断中心、门诊手术中心等）、分销渠道（零售、在线销售和直接招标） |
|
覆盖国家 |
德国、法国、英国、意大利、西班牙、荷兰、瑞士、比利时、土耳其和欧洲其他地区 |
|
涵盖的市场参与者 |
在市场上运营的主要公司有 Medline Industries LP、Deas srl、HR Pharmaceuticals Inc、FIAB SpA、Gima SpA、Parker Laboratories Inc、Primax Berlin GmbH、Optimum Medical Limited、Safersonic、Braun and Co. Limited、ProSys International Ltd、Turquoise Health、DJO LLC、Fannin、Lessa（AB Medica Group 的子公司）、Rays SPA 等 |
市场定义：
超声波凝胶是超声波检查过程中最常用的凝胶之一。超声波凝胶用于在诊断过程中获得清晰准确的成像。这些是涂在皮肤上的导电介质，可作为耦合剂，因此有助于在皮肤和探头之间形成紧密结合。这种凝胶还有助于超声波直接传送到组织和其他需要成像的部位。
超声波凝胶市场动态
驱动程序
- 超声波检查程序
高频声波可进行超声波扫描，对人体内部结构进行成像。医生或临床医师将超声波凝胶涂抹在患者的身体部位，以获得深度、精确和清晰的医学成像。随着不断发展的技术使医学超声波能够提供高分辨率图像，正确诊断体内情况变得越来越容易。由于其成本效益高，并且人们对定期体检以保持身体健康的意识不断增强，超声波扫描的数量正在增加。超声波凝胶是这些扫描中最方便、最可靠的产品。临床医师和医生对超声波的依赖性不断增加。这些程序通常用于检查肝脏、肾脏和胃、骨盆中的其他器官以及可以通过皮肤评估的其他器官或组织。老年人口增加
- 易于使用且患者友好型诊断
扫描时，临床医生、医生和医务人员最常使用超声波凝胶，因为这些凝胶有助于防止超声波从扫描仪传到涂有凝胶的身体部位时出现空气。大多数超声波程序都是无痛的，因为它们是非侵入性的，并且是在外部进行的，只需将凝胶涂在身体上，并将换能器放置在靠近皮肤的位置，当它传递光波时，这对人的身体的影响可以忽略不计。超声波程序使用高频声波来创建身体内部部分的图像，因为超声波凝胶最能捕捉这些图像。这些涂在皮肤上的凝胶易于使用，不会引起任何身体疼痛。因此，简单无痛的超声波程序将有助于预测期内市场的增长
机会
-
医疗支出增长
随着各国人民的可支配收入增加，全球医疗保健支出也随之增加。此外，为了满足人口需求，政府机构和医疗保健组织正在采取主动行动，加快医疗保健支出。此外，该地区政府医疗保健支出的增加将为 2022-2029 年预测期内的超声波凝胶市场提供结构完整性和未来机会。
限制/挑战
据报道，使用超声波凝胶会导致各种皮肤问题和过敏。有些人因为皮肤敏感而出现这些问题。一小部分患者因使用超声波凝胶而患上接触性皮炎。有时，患者涂抹凝胶的皮肤上也可能出现细菌污染。由于放热反应，某些配方或不同成分的凝胶在紫外线下处理时会发热。凝胶越厚，产生的热量就越多。因此，使用超声波凝胶的副作用可能会阻碍预测期内的市场增长。
新冠肺炎疫情对欧洲超声波凝胶市场的影响
COVID-19影响了市场的增长，因为该地区的超声检查程序有所增加，例如宫腔超声检查、产科超声、腹部超声、乳房超声、颈动脉超声、肌肉骨骼超声、盆腔超声、前列腺超声、阴囊超声、甲状腺超声、静脉超声等。因此，在 COVID 期间，对超声凝胶的需求不断增加。
近期发展
- 2019 年 4 月，Civco Medical Solutions 推出了一款新解决方案 Envision Viral Barrier，该解决方案消除了超声程序中凝胶的使用。该产品由一个超声探头盖和一个带有无菌液体的扫描垫组成，可实现 100% 无凝胶程序。此类技术进步有助于降低污染风险并简化医疗环境中的临床医生工作流程，这可能会阻碍市场增长
欧洲超声波凝胶市场范围
欧洲超声波凝胶市场分为类型、应用、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
应用
根据应用，欧洲超声波凝胶市场细分为腹部超声波、产科超声波、宫腔超声波、盆腔超声波、肌肉骨骼超声波、乳腺超声波、前列腺超声波、颈动脉超声波、静脉超声波（四肢）、阴囊超声波、甲状腺超声波等。
类型
- 无菌超声波凝胶
- 非无菌超声波凝胶
根据类型，欧洲超声波凝胶市场分为无菌超声波凝胶和非无菌超声波凝胶。
最终用户
- 医院
- 诊所
- 诊断中心
- 门诊手术中心
- 其他的
根据最终用户，欧洲超声波凝胶市场分为医院、诊所、诊断中心、门诊手术中心和其他。
分销渠道
- 零售销售
- 网上销售
- 直接招标
根据分销渠道，欧洲超声波凝胶市场分为零售、在线销售和直接招标。
市场定义
超声波凝胶是常用的凝胶之一，主要用于超声波检查。超声波凝胶用于在诊断过程中获得清晰准确的成像，它们是一种导电介质，涂在皮肤上，充当耦合剂，因此有助于在皮肤和探头之间形成紧密结合。这种凝胶还有助于超声波直接传送到组织和其他需要成像的部位。
欧洲超声波凝胶市场区域分析/见解
对超声波凝胶市场进行了分析，并按国家、类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
欧洲超声波凝胶市场包括德国、法国、英国、意大利、西班牙、荷兰、瑞士、比利时、土耳其和欧洲其他国家。
德国在市场份额和市场收入方面占据超声波凝胶市场的主导地位，并将在预测期内继续保持主导地位。这是由于各种慢性病患病率的上升以及德国药物研发的研发进一步促进了这一市场的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和市场份额分析
超声波凝胶市场竞争格局提供了有关竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上数据点仅与专注于欧洲超声波凝胶市场的公司有关。
欧洲超声波凝胶市场的一些主要参与者包括 Medline Industries LP、Deas srl、HR Pharmaceuticals Inc、FIAB SpA、Gima SpA、Parker Laboratories Inc、Primax Berlin GmbH、Optimum Medical Limited、Safersonic、Braun and Co. Limited、ProSys International Ltd、Turquoise Health、DJO LLC、Fannin、Lessa（AB Medica Group 的子公司）、Rays SPA 等。
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区和供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE ULTRASOUND GELS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 NUMBER OF ULTRASOUND PROCEDURES, BY COUNTRY
4.3.1 NUMBER OF ABDOMINAL ULTRASOUND PROCEDURES, BY COUNTRY
4.3.2 NUMBER OF OBSTETRIC ULTRASOUND PROCEDURES, BY COUNTRY
4.3.3 NUMBER OF HYSTEROSONOGRAPHY ULTRASOUND PROCEDURES, BY COUNTRY
4.3.4 NUMBER OF BREAST ULTRASOUND PROCEDURES, BY COUNTRY
4.3.5 NUMBER OF CAROTID ULTRASOUND PROCEDURES, BY COUNTRY
4.3.6 NUMBER OF MUSCULOSKELETAL ULTRASOUND PROCEDURES, BY COUNTRY
4.3.7 NUMBER OF PELVIC ULTRASOUND PROCEDURES, BY COUNTRY
4.3.8 NUMBER OF PROSTATE ULTRASOUND PROCEDURES, BY COUNTRY
4.3.9 NUMBER OF SCROTAL ULTRASOUND PROCEDURES, BY COUNTRY
4.3.10 NUMBER OF THYROID ULTRASOUND PROCEDURES, BY COUNTRY
4.3.11 NUMBER OF VENOUS (EXTREMITIES) ULTRASOUND PROCEDURES, BY COUNTRY
5 EUROPE ULTRASOUND GELS MARKET: REGULATIONS
5.1 REGULATION IN EUROPE
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING ULTRASOUND PROCEDURES
6.1.2 EASY USAGE AND PATIENT-FRIENDLY PAINLESS DIAGNOSIS
6.1.3 VERSATILE IN NATURE, HAVE VARIOUS DIFFERENT FORMULATIONS
6.2 RESTRAINTS
6.2.1 UNPLEASANT SIDE EFFECTS SUCH AS ALLERGIES OR SKIN PROBLEMS
6.2.2 LOW-COST SUBSTITUTES
6.3 OPPORTUNITIES
6.3.1 RISE IN HEALTHCARE EXPENDITURE
6.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
6.3.3 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS
6.4 CHALLENGES
6.4.1 UPCOMING TECHNOLOGICAL ADVANCEMENTS ELIMINATING THE USE OF ULTRASOUND GEL
6.4.2 RISK ASSOCIATED WITH USE OF NON-STERILE ULTRASOUND GEL IN GERIATRIC PATIENTS
7 EUROPE ULTRASOUND GELS MARKET, BY TYPE
7.1 OVERVIEW
7.2 NON-STERILE ULTRASOUND GELS
7.3 STERILE ULTRASOUND GELS
8 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ABDOMINAL ULTRASOUND
8.2.1 NON-STERILE ULTRASOUND GELS
8.2.2 STERILE ULTRASOUND GELS
8.3 OBSTETRIC ULTRASOUND
8.3.1 NON-STERILE ULTRASOUND GELS
8.3.2 STERILE ULTRASOUND GELS
8.4 HYSTEROSONOGRAPHY
8.4.1 NON-STERILE ULTRASOUND GELS
8.4.2 STERILE ULTRASOUND GELS
8.5 PELVIC ULTRASOUND
8.5.1 NON-STERILE ULTRASOUND GELS
8.5.2 STERILE ULTRASOUND GELS
8.6 MUSCULOSKELETAL ULTRASOUND
8.6.1 NON-STERILE ULTRASOUND GELS
8.6.2 STERILE ULTRASOUND GELS
8.7 BREAST ULTRASOUND
8.7.1 NON-STERILE ULTRASOUND GELS
8.7.2 STERILE ULTRASOUND GELS
8.8 PROSTATE ULTRASOUND
8.8.1 NON-STERILE ULTRASOUND GELS
8.8.2 STERILE ULTRASOUND GELS
8.9 CAROTID ULTRASOUND
8.9.1 NON-STERILE ULTRASOUND GELS
8.9.2 STERILE ULTRASOUND GELS
8.1 VENOUS ULTRASOUND (EXTERMITIS)
8.10.1 NON-STERILE ULTRASOUND GELS
8.10.2 STERILE ULTRASOUND GELS
8.11 SCROTAL ULTRASOUND
8.11.1 NON-STERILE ULTRASOUND GELS
8.11.2 STERILE ULTRASOUND GELS
8.12 THYROID ULTRASOUND
8.12.1 NON-STERILE ULTRASOUND GELS
8.12.2 STERILE ULTRASOUND GELS
8.13 OTHERS
9 EUROPE ULTRASOUND GELS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 DIAGNOSTIC CENTERS
9.4 CLINICS
9.5 AMBULATORY SURGICAL CENTERS
9.6 OTHERS
10 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.3 ONLINE SALES
10.4 DIRECT TENDER
11 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY
11.1 GERMANY
11.2 FRANCE
11.3 U.K.
11.4 ITALY
11.5 TURKEY
11.6 SPAIN
11.7 NETHERLANDS
11.8 BELGIUM
11.9 SWITZERLAND
11.1 REST OF EUROPE
12 EUROPE ULTRASOUND GELS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 PARKER LABORATORIES, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 PRODUCT PORTFOLIO
14.1.3 RECENT DEVELOPMENTS
14.2 OPTIMUM MEDICAL LIMITED
14.2.1 COMPANY SNAPSHOT
14.2.2 PRODUCT PORTFOLIO
14.2.3 RECENT DEVELOPMENTS
14.3 FIAB SPA
14.3.1 COMPANY SNAPSHOT
14.3.2 PRODUCT PORTFOLIO
14.3.3 RECENT DEVELOPMENTS
14.4 DEAS S.R.L.
14.4.1 COMPANY SNAPSHOT
14.4.2 PRODUCT PORTFOLIO
14.4.3 RECENT DEVELOPMENTS
14.5 HR PHARMACEUTICALS, INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENTS
14.6 BRAUN & CO. LIMITED
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 DJO, LLC
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 FANNIN
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 GIMA S.P.A.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 LESSA (SUBSIDIARY OF AB MEDICA GROUP)
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 MEDLINE INDUSTRIES, LP.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 PRIMAX BERLIN GMBH
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 PROSYS INTERNATIONAL LTD
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 RAYS S.P.A
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 SAFERSONIC
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 TURQUOISE HEALTH
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 2 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (VOLUME, IN THOUSAND)
TABLE 3 EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (ASP)
TABLE 4 EUROPE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 5 EUROPE ABDOMINAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 6 EUROPE OBSTETRIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 7 EUROPE HYSTEROSONOGRAPHY IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 8 EUROPE PELVIC ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 9 EUROPE MUSCULOSKELETAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 10 EUROPE BREAST ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 11 EUROPE PROSTATE ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 12 EUROPE CAROTID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 13 EUROPE VENOUS ULTRASOUND (EXTREMITIS) IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 14 EUROPE SCROTAL ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 15 EUROPE THYROID ULTRASOUND IN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 16 EUROPE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 17 EUROPE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 18 EUROPE ULTRASOUND GELS MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 19 GERMANY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 20 GERMANY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 21 GERMANY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 22 GERMANY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 23 GERMANY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 24 GERMANY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 25 GERMANY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 26 ERMANY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 27 GERMANY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 28 GERMANY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 29 GERMANY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 30 GERMANY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 31 GERMANY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 32 GERMANY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 33 GERMANY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 34 FRANCE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 35 FRANCE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 36 FRANCE ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 37 FRANCE OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 38 FRANCE HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 39 FRANCE PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 40 FRANCE MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 41 FRANCE BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 42 FRANCE PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 43 FRANCE CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 44 FRANCE VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 45 FRANCE SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 46 FRANCE THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 47 FRANCE ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 48 FRANCE ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 49 U.K. ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 50 U.K. ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 51 U.K. ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 52 U.K. OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 53 U.K. HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 54 U.K. PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 55 U.K. MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 56 U.K. BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 57 U.K. PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 58 U.K. CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 59 U.K. VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 60 U.K. SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 61 U.K. THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 62 U.K. ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 63 U.K. ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 64 ITALY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 65 ITALY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 66 ITALY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 67 ITALY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 68 ITALY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 69 ITALY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 70 ITALY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 71 ITALY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 72 ITALY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 73 ITALY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 74 ITALY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 75 ITALY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 76 ITALY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 77 ITALY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 78 ITALY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 79 TURKEY ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 80 TURKEY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 81 TURKEY ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 82 TURKEY OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 83 TURKEY HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 84 TURKEY PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 85 TURKEY MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 86 TURKEY BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 87 TURKEY PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 88 TURKEY CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 89 TURKEY VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 90 TURKEY SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 91 TURKEY THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 92 TURKEY ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 93 TURKEY ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 94 SPAIN ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 95 SPAIN ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 96 SPAIN ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 97 SPAIN OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 98 SPAIN HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 99 SPAIN PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 100 SPAIN MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 101 SPAIN BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 102 SPAIN PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 103 SPAIN CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 104 SPAIN VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 105 SPAIN SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 106 SPAIN THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 107 SPAIN ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 108 SPAIN ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 109 NETHERLANDS ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 110 NETHERLANDS ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 111 NETHERLANDS ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 112 NETHERLANDS OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 113 NETHERLANDS HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 114 NETHERLANDS PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 115 NETHERLANDS MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 116 NETHERLANDS BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 117 NETHERLANDS PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 118 NETHERLANDS CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 119 NETHERLANDS VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 120 NETHERLANDS SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 121 NETHERLANDS THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 122 NETHERLANDS ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 123 NETHERLANDS ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 124 BELGIUM ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 125 BELGIUM ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 126 BELGIUM ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 127 BELGIUM OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 128 BELGIUM HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 129 BELGIUM PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 130 BELGIUM MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 131 BELGIUM BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 132 BELGIUM PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 133 BELGIUM CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 134 BELGIUM VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 135 BELGIUM SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 136 BELGIUM THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 137 BELGIUM ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 138 BELGIUM ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 139 SWITZERLAND ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 140 SWITZERLAND ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 141 SWITZERLAND ABDOMINAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 142 SWITZERLAND OBSTETRIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 143 SWITZERLAND HYSTEROSONOGRAPHY ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 144 SWITZERLAND PELVIC ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 145 SWITZERLAND MUSCULOSKELETAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 146 SWITZERLAND BREAST ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 147 SWITZERLAND PROSTATE ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 148 SWITZERLAND CAROTID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 149 SWITZERLAND VENOUS ULTRASOUND (EXTERMITIS) GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 150 SWITZERLAND SCROTAL ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 151 SWITZERLAND THYROID ULTRASOUND GELS MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 152 SWITZERLAND ULTRASOUND GELS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 153 SWITZERLAND ULTRASOUND GELS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 154 REST OF EUROPE ULTRASOUND GELS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION
FIGURE 2 EUROPE ULTRASOUND GELS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ULTRASOUND GELS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ULTRASOUND GELS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE ULTRASOUND GELS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ULTRASOUND GELS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ULTRASOUND GELS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE ULTRASOUND GELS MARKET: MARKET END-USER COVERAGE GRID
FIGURE 9 EUROPE ULTRASOUND GELS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE ULTRASOUND GELS MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF ULTRASOUND PROCEDURES AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE ULTRASOUND GELS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 THE NON-STERILE ULTRASOUND GELS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ULTRASOUND GELS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL MRI COILS MARKET
FIGURE 14 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2021
FIGURE 15 EUROPE ULTRASOUND GELS MARKET: BY TYPE, 2022-2029 (USD THOUSAND)
FIGURE 16 EUROPE ULTRASOUND GELS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 17 EUROPE ULTRASOUND GELS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2021
FIGURE 19 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, 2022-2029 (USD THOUSAND)
FIGURE 20 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 21 EUROPE ULTRASOUND GELS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2021
FIGURE 23 EUROPE ULTRASOUND GELS MARKET: BY END USER, 2022-2029 (USD THOUSAND)
FIGURE 24 EUROPE ULTRASOUND GELS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 25 EUROPE ULTRASOUND GELS MARKET: BY END USER, LIFELINE CURVE
FIGURE 26 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 27 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD THOUSAND)
FIGURE 28 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 29 EUROPE ULTRASOUND GELS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 30 EUROPE ULTRASOUND GELS MARKET: SNAPSHOT (2021)
FIGURE 31 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021)
FIGURE 32 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE ULTRASOUND GELS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE ULTRASOUND GELS MARKET: BY TYPE (2022 & 2029)
FIGURE 35 EUROPE ULTRASOUND GELS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
